Evidence map›Paper›PMID 42532997›Full record

ArticleNature communications2026

Golgi organization regulates stem cell function in the small intestine.

Ilya Belevich, Lucas Porcile, Agustin Sola-Carvajal, David Grommisch, Karl Annusvar, Paul Heinz, Srustidhar Das, Anna T Webb, Simon Andersson, Nalle Pentinmikko and 7 more

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

17 authors.

Ilya BelevichInstitute of Biotechnology, Helsinki Institute of Life Science, University of Helsinki, Helsinki, Finland.ORCID 0000-0003-2190-4909
Lucas PorcileDepartment of Cell and Molecular Biology (CMB), Karolinska Institutet, Stockholm, Sweden.
Agustin Sola-CarvajalDepartment of Cell and Molecular Biology (CMB), Karolinska Institutet, Stockholm, Sweden.ORCID 0000-0001-6568-0682
David GrommischMax Planck Institute of Molecular Cell Biology and Genetics, Dresden, Germany.ORCID 0000-0002-2666-1419
Karl AnnusvarDepartment of Cell and Molecular Biology (CMB), Karolinska Institutet, Stockholm, Sweden.ORCID 0000-0002-9515-7216
Paul HeinzDepartment of Cell and Molecular Biology (CMB), Karolinska Institutet, Stockholm, Sweden.
Srustidhar DasDivision of Immunology and Allergy, Department of Medicine, Karolinska Institutet and University Hospital, Stockholm, Sweden.ORCID 0000-0002-0833-588X
Anna T WebbDepartment of Cell and Molecular Biology (CMB), Karolinska Institutet, Stockholm, Sweden.
Simon AnderssonInstitute of Biotechnology, Helsinki Institute of Life Science, University of Helsinki, Helsinki, Finland.
Nalle PentinmikkoInstitute of Biotechnology, Helsinki Institute of Life Science, University of Helsinki, Helsinki, Finland.ORCID 0000-0003-3578-1073
Eduardo J VillablancaDivision of Immunology and Allergy, Department of Medicine, Karolinska Institutet and University Hospital, Stockholm, Sweden.ORCID 0000-0001-9522-9729
James R GoldenringSection of Surgical Sciences, Department of Cell and Developmental Biology, and the Epithelial Biology Center, Vanderbilt University Medical Center, Nashville, TN, USA.ORCID 0000-0002-7833-2940
Maria KasperDepartment of Cell and Molecular Biology (CMB), Karolinska Institutet, Stockholm, Sweden.ORCID 0000-0002-6117-2717
Eija JokitaloInstitute of Biotechnology, Helsinki Institute of Life Science, University of Helsinki, Helsinki, Finland.ORCID 0000-0002-4159-6934
Robert J CoffeyDepartment of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.ORCID 0000-0002-2180-3844
Pekka KatajistoInstitute of Biotechnology, Helsinki Institute of Life Science, University of Helsinki, Helsinki, Finland. pekka.katajisto@ki.se.ORCID 0000-0002-3033-4189
Sandra ScharawDepartment of Cell and Molecular Biology (CMB), Karolinska Institutet, Stockholm, Sweden. scharaw@mpi-cbg.de.ORCID 0000-0001-9428-3213

Funding

Vanderbilt-Ingram Cancer Center SPORE in Gastrointestinal CancerP50CA236733 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI STEPHEN W. FESIK · 2019 to 2026
$19.6M
Integrated approach to study early and late events in colonic neoplasia: mouse to manR35CA197570 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Robert J. Coffey · 2017 to 2026
$9.4M
NCI NIH HHS P50 CA236733NCI NIH HHS R35 CA197570
6 · The paper itself

Abstract

Cell-to-cell signaling between niche and stem cells regulates tissue renewal. While the identity of many mediating factors is known, it is largely unknown whether stem cells optimize their receptiveness to niche signals according to the niche organization. Here, we show that Lgr5+ small intestinal stem cells (ISCs) regulate the morphology and orientation of their secretory apparatus to match the niche architecture, and to increase transport efficiency of niche signal receptors. ISCs orient their Golgi apparatus laterally towards Paneth cells of the epithelial niche, and divide Golgi into multiple stacks. Stem cells with multiple lateral Golgi transport stem cell receptors with a higher efficiency than cells with one single Golgi. The lateral Golgi orientation and enhanced receptor transport requires A-kinase anchor protein 9 (Akap9), and is necessary for normal renewal capacity. Moreover, reduced Akap9 in aged ISCs renders ISCs insensitive to niche-dependent modulation of Golgi stack number and transport efficiency. Our results reveal a stem cell-specific Golgi complex configuration that facilitates efficient niche signal reception and tissue renewal, which is compromised in the aged epithelium.

Indexed as

Golgi ApparatusIntestine, SmallStem CellsA Kinase Anchor ProteinsAnimalsMiceMice, Inbred C57BLPaneth CellsReceptors, G-Protein-CoupledSignal TransductionStem Cell NicheA Kinase Anchor ProteinsLgr5 protein, mouseReceptors, G-Protein-Coupled

Identifiers

PMID42532997
PMCPMC13424321

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.